Physician Information2023-03-08T17:16:55-05:00

WM Information for Physicians

Our goal is to make the selection of information here useful to the medical community at large.  Thus the information here may not necessarily be easily consumed by the public.  But all are welcome to this collection of WM-related information.

Multi-omic Analysis Yields Significant WM Insights

March 3rd, 2023|

Partially funded by the WMFC and presented at ASH in December, 2022, this research identified three subtypes of WM.

The full abstract that Dr. Hunter presented at ASH is available here.

Two other WM-related abstracts using the multiomic analysis from Dr. Hunter’s research were also presented at ASH:

  • An in-depth investigation into why epigenomic regulation is so important to MYD88 mutations is available here
  • The data also has been applied to investigating why ibrutinib (and by extension other BTK inhibitors) may result in long Progression-Free Survival (PFS); that abstract is available here


Donate today:

Join the WMFC and stay in the loop!

Get the latest news, events and membership information via email.

Go to Top